The impact of aminophylline on incidence and severity of post-dural puncture headache: A meta-analysis of randomised controlled trials

doi:10.1016/j.accpm.2021.100920

CNU IR > Pharmacy and Science > Dept. of Health and Nutrition (including master's program) > Periodical Articles > Item 310902800/34394

Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/34394

Title:	The impact of aminophylline on incidence and severity of post-dural puncture headache: A meta-analysis of randomised controlled trials
Authors:	Hung, Kuo-Chuan Ho, Chun-Ning Chen, I-Wen Hung, I. -Yin Lin, Ming-Chung Lin, Chien -Ming Wang, Li -Kai Chen, Jen-Yin Sun, Cheuk-Kwan
Contributors:	Chi Mei Med Ctr, Dept Anaesthesiol Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr E Da Hosp, Dept Emergency Med I Shou Univ, Coll Med
Keywords:	Aminophylline Post-dural puncture headache Spinal headache Regional anaesthesia Regional analgesia
Date:	2021
Issue Date:	2023-11-11 11:49:26 (UTC+8)
Publisher:	ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
Abstract:	Background: This meta-analysis aimed at addressing the impact of aminophylline use on risk and severity of post-dural puncture headache (PDPH). Methods: Electronic databases (i.e., Medline, Embase, and the Cochrane controlled trials register) were searched from inception to the 12 th of January 2021 for randomised controlled trials (RCTs) that assessed the efficacy of aminophylline for treatment (i.e., primary outcome) or prophylaxis (i.e., secondary outcome) against PDPH in various clinical settings. The study is registered with PROSPERO (CRD42020207713). Results: A total of ten RCTs (n = 976) were included for analysis. Five studies (n = 270) revealed a lower pain score in patients with PDPH receiving aminophylline than that in the placebo group (standardised mean differences = -1.34, 95% confidence interval (CI): -1.76 to -0.91). In contrast, five trials (four on Caesarean sections and one on lower extremity surgeries, n = 706) demonstrated no prophylactic effect of aminophylline against PDPH at 24 [risk ratio (RR) = 0.70, 95% CI: 0.30-1.63, n = 637], 48 (RR = 0.48, 95% CI: 0.22-1.05, n = 506), and 72 (RR = 0.89, 95% CI: 0.54-1.48, n = 317) hours. Nevertheless, sensitivity analysis demonstrated significant prophylactic efficacy after removal of one study adopting a relatively low dose of aminophylline (RR = 0.36, 95% CI: 0.19-0.67). Most studies reported no increase in the incidence of adverse events associated with aminophylline use compared with that in the control group. Conclusion: Our results indicated that aminophylline might be a reasonable alternative for treating PDPH. However, its use for prevention was not established in this meta-analysis and further large-scale studies are warranted to support this option. (C) 2021 Societe francaise d'anesthesie et de reanimation (Sfar). Published by Elsevier Masson SAS. All rights reserved.
Relation:	ANAESTH CRIT CARE PA, v.40, n.4
Appears in Collections:	[Dept. of Health and Nutrition (including master's program)] Periodical Articles

Files in This Item:

File	Description	Size	Format
index.html		0Kb	HTML	186	View/Open

Loading...